» Articles » PMID: 10546691

The Disease Burden Associated with Overweight and Obesity

Overview
Journal JAMA
Specialty General Medicine
Date 1999 Nov 5
PMID 10546691
Citations 1258
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Overweight and obesity are increasing dramatically in the United States and most likely contribute substantially to the burden of chronic health conditions.

Objective: To describe the relationship between weight status and prevalence of health conditions by severity of overweight and obesity in the US population.

Design And Setting: Nationally representative cross-sectional survey using data from the Third National Health and Nutrition Examination Survey (NHANES III), which was conducted in 2 phases from 1988 to 1994.

Participants: A total of 16884 adults, 25 years and older, classified as overweight and obese (body mass index [BMI] > or =25 kg/m2) based on National Institutes of Health recommended guidelines.

Main Outcome Measures: Prevalence of type 2 diabetes mellitus, gallbladder disease, coronary heart disease, high blood cholesterol level, high blood pressure, or osteoarthritis.

Results: Sixty-three percent of men and 55% of women had a body mass index of 25 kg/m2 or greater. A graded increase in the prevalence ratio (PR) was observed with increasing severity of overweight and obesity for all of the health outcomes except for coronary heart disease in men and high blood cholesterol level in both men and women. With normal-weight individuals as the reference, for individuals with BMIs of at least 40 kg/m2 and who were younger than 55 years, PRs were highest for type 2 diabetes for men (PR, 18.1; 95% confidence interval [CI], 6.7-46.8) and women (PR, 12.9; 95% CI, 5.7-28.1) and gallbladder disease for men (PR, 21.1; 95% CI, 4.1-84.2) and women (PR, 5.2; 95% CI, 2.9-8.9). Prevalence ratios generally were greater in younger than in older adults. The prevalence of having 2 or more health conditions increased with weight status category across all racial and ethnic subgroups.

Conclusions: Based on these results, more than half of all US adults are considered overweight or obese. The prevalence of obesity-related comorbidities emphasizes the need for concerted efforts to prevent and treat obesity rather than just its associated comorbidities.

Citing Articles

Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF Program.

De Caterina R, Unverdorben M, Chen C, Choi E, Koretsune Y, Morrone D Clin Cardiol. 2025; 48(3):e70091.

PMID: 40014354 PMC: 11885795. DOI: 10.1002/clc.70091.


Obesity and overweight and associated factors among women with infertility undergoing assisted reproductive technology treatment in a low income setting.

Amoah C, Adageba R, Appiah E, Sefogah P Sci Rep. 2025; 15(1):6163.

PMID: 39979328 PMC: 11842771. DOI: 10.1038/s41598-024-82818-5.


Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.

Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.

PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.


The Effects of Yoga on Key Adipocytokines in Obesity: A Narrative Review of Leptin and Adiponectin.

Shimizu R, Suzuki H, Amitani M, Amitani H Cureus. 2025; 17(1):e76792.

PMID: 39897330 PMC: 11786781. DOI: 10.7759/cureus.76792.


Racial and Ethnic Disparities in Pediatric Counseling on Nutrition, Lifestyle, and Weight: A Secondary Analysis of the BP-CATCH Randomized Clinical Trial.

Heo M, Rea C, Brady T, Bundy D, Melikam E, Orringer K JAMA Netw Open. 2025; 8(1):e2456238.

PMID: 39878982 PMC: 11780477. DOI: 10.1001/jamanetworkopen.2024.56238.